Sumitomo Pharma Co., Ltd. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Sumitomo Pharma Co., Ltd. (SPL or 'the company'), formerly Sumitomo Dainippon Pharma Co Ltd, a subsidiary of Sumitomo Chemical Co Ltd, is a developer, manufacturer, and importer of global pharmaceutical products. The company focuses on major therapeutic areas which include cardiovascular, central nervous system (CNS), diabetes, respiratory psychiatry, oncology and neurology diseases. SPL also owns and operates manufacturing and distribution facilities, and research laboratories in Japan. It operates in countries across North America, the Asia Pacific and other regions of the world through its subsidiaries. The company is headquartered in Chuo-Ku, Osaka, Japan.Scope
- Detailed information on Sumitomo Pharma Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sumitomo Pharma Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Sumitomo Pharma Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Sumitomo Pharma Co., Ltd.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sumitomo Pharma Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Sumitomo Pharma Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sumitomo Pharma Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Sumitomo Pharma Co., Ltd.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Sumitomo Pharma Co., Ltd.: Company Overview
- Sumitomo Pharma Co., Ltd.: Overview and Key Facts
- Sumitomo Pharma Co., Ltd.: Overview
- Sumitomo Pharma Co., Ltd.: Key Facts
- Sumitomo Pharma Co., Ltd.: Key Employees
- Sumitomo Pharma Co., Ltd.: Key Employee Biographies
- Sumitomo Pharma Co., Ltd.: Major Products and Services
- Sumitomo Pharma Co., Ltd.: Company History
- Sumitomo Pharma Co., Ltd.: Management Statement
- Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
- Sumitomo Pharma Co., Ltd.: Key Competitors
- Sumitomo Pharma Co., Ltd.: Company Analysis
- Sumitomo Pharma Co., Ltd.: Business Description
- Sumitomo Pharma Co., Ltd.: SWOT Analysis
- Sumitomo Pharma Co., Ltd.: SWOT Overview
- Sumitomo Pharma Co., Ltd.: Strengths
- Sumitomo Pharma Co., Ltd.: Weaknesses
- Sumitomo Pharma Co., Ltd.: Opportunities
- Sumitomo Pharma Co., Ltd.: Threats
- Sumitomo Pharma Co., Ltd.: Corporate Financial Deals Activity
- Sumitomo Pharma Co., Ltd.: Financial Deals Overview
- Sumitomo Pharma Co., Ltd.: Targets and Partners
- Sumitomo Pharma Co., Ltd.: Top Deals 2021 - 2025YTD*
- Sumitomo Pharma Co., Ltd.: Advisors
- Sumitomo Pharma Co., Ltd.: Top Legal Advisors
- Sumitomo Pharma Co., Ltd.: Mergers and Acquisitions
- Sumitomo Pharma Co., Ltd.: Partnership
- Sumitomo Pharma Co., Ltd.: Divestments
- Sumitomo Pharma Co., Ltd.: Recent Developments
- Sumitomo Pharma Co., Ltd.: News and Events Summary
- Sumitomo Pharma Co., Ltd.: Business Reorganization
- Sumitomo Pharma Co., Ltd.: Corporate Governance
- Sumitomo Pharma Co., Ltd.: Financial Performance
- Sumitomo Pharma Co., Ltd.: Market Developments
- Sumitomo Pharma Co., Ltd.: Research & Development
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
Table 1: Sumitomo Pharma Co., Ltd.: Key Facts
Table 2: Sumitomo Pharma Co., Ltd.: Key Employees
Table 3: Sumitomo Pharma Co., Ltd.: Company History
Table 4: Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
Table 5: Sumitomo Pharma Co., Ltd.: Key Competitors
Table 6: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 8: Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Table 9: Sumitomo Pharma Co., Ltd.: Targets and Partners
Table 10: Sumitomo Pharma Co., Ltd.: Top Deals 2021 - 2025YTD*
Table 11: Sumitomo Pharma Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 12: Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2021 - YTD*2025)
Table 13: Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2021 - YTD*2025)
Table 14: Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 15: Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 16: Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 17: Sumitomo Pharma Co., Ltd.: Divestments by Geography (2021 - YTD*2025)
Table 18: Sumitomo Pharma Co., Ltd.: News and Events Summary
Table 19: Sumitomo Pharma Co., Ltd.: Business Reorganization
Table 20: Sumitomo Pharma Co., Ltd.: Corporate Governance
Table 21: Sumitomo Pharma Co., Ltd.: Financial Performance
Table 22: Sumitomo Pharma Co., Ltd.: Market Developments
Table 23: Sumitomo Pharma Co., Ltd.: Research & Development
List of Figures
Figure 1: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Figure 4: Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 5: Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2021 - YTD*2025)
Figure 6: Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 7: Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2021 - YTD*2025)
Figure 8: Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2021 - YTD*2025)
Figure 9: Sumitomo Pharma Co., Ltd.: Divestments by Geography (2021 - YTD*2025)
